cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.3mjpxd
title: Occurrence Download

description: A dataset containing 80826 species occurrences available in GBIF matching the query:
{
 "and" : [
 "VerbatimScientificName is Poliocephalus poliocephalus",
 "BasisOfRecord is one of (Machine Observation, Human Observation)",
 "Year 2011-2021",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen, Specimen, Material citation, Material sample)"
 ]
 }
 }
 ]
}

 The dataset includes 80826 records from 22 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081316-230530130749713/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.8129417
title: Additional file 3: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S2. The primer sequences for PCR and pyrosequencing. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.14944930
title: Additional file 6 of Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells

description: Additional file 6: Table S5. Summary of CNVs containing TEs in naïve and primed PSCs in two different genetic background cell lines.
DOI: 10.6084/m9.figshare.12847978.v1
title: Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis

description: <b>Background:</b> Both experimental and observational studies have provided conflicting evidence on the associations of selenium with incidence and mortality of cardiovascular disease (CVD). The aim of this study was to evaluate the association between selenium status in the body and incidence and mortality of CVD by performing a systematic review and meta-analysis of observational studies and randomized controlled trials. <b>Methods:</b> A systematic search for articles in MEDLINE (Ovid), Embase, Web of Science (Thomson Reuters) and Cochrane library (Wiley) was conducted. Thirteen of the 1811 articles obtained from the databases met our inclusion criteria and were considered in the final analysis. The effect sizes were presented as weighted relative risk (RR) and 95% confidence intervals (CIs) using random-effects model. To detect dose-response relationships, we used meta-regression. <b>Results:</b> Overall, there was a reduced risk of CVD incidence (RR = 0.66; 95% CI: 0.40–1.09) and mortality (RR = 0.69; 95% CI: 0.57–0.84) in physiologically high selenium status compared to low selenium status in the body. There was a 15% (RR = 0.85, 95% CI: 0.76–0.94) decreased risk of CVD incidence per 10 µg increment in blood selenium concentration. In addition, a statistically significantly nonlinear dose-response relationship was found between CVD mortality and increased blood selenium concentration with the lowest risk at the 30–35 µg increment in blood selenium. <b>Conclusions:</b> Physiologically high selenium levels in the body are associated with decreased risk for CVD incidence and mortality, however, people should be cautious about the potential harmful effects from excessive intake of selenium.
DOI: 10.6084/m9.figshare.14944927.v1
title: Additional file 5 of Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells

description: Additional file 5: Table S4. Differential TE transcriptome at passage 15.
DOI: 10.6084/m9.figshare.8129462.v1
title: Additional file 9: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S5. Univariate and multivariate Cox regression analyses in low-risk group of non-G-CIMP (or HSPB2 hypermethylated IDH1R132H wt) GBMs. (XLSX 23 kb)
DOI: 10.25381/cput.23791530
title: The effect of the fungus <i>Beauveria bassiana </i>(Hypocreales) on the growth of <i>Tulbaghia violacea </i>and its ability to synthesize nano-particle insecticidal to mealybug

description: Can the entomopathogenic fungus <i>Beauveria bassiana</i> colonize wild garlic and induce enhanced bioactivity of the plant extracts? This study aimed to evaluate the effect of the entomopathogenic fungus <i>Beauveria bassiana</i> (Hypocreales) on the growth and ability of <i>Tulbaghia violacea</i> (wild garlic) to synthesise nanoparticles. <i>T. violacea </i>Harv.<i> </i>plants were inoculated by drenching with different concentrations of <i>B. bassiana</i> conidia. This dataset improves our understanding of the relationship between plants and endophytic fungi. This Faculty Research Ethics Committee of the Faculty of Applied Sciences granted ethics approval for this study, Reference no 212274759/1/2019.
DOI: 10.25381/cput.23791530.v2
title: <b>The effect of the fungus </b><b><i>Beauveria bassiana </i></b><b>(Hypocreales) on the growth of </b><b><i>Tulbaghia violacea </i></b><b>and its ability to synthesize nano-particle insecticidal to mealybug</b>

description: Can the entomopathogenic fungus <i>Beauveria bassiana</i> colonize wild garlic and induce enhanced bioactivity of the plant extracts? This study aimed to evaluate the effect of the entomopathogenic fungus <i>Beauveria bassiana</i> (Hypocreales) on the growth and ability of <i>Tulbaghia violacea</i> (wild garlic) to synthesise nanoparticles. <i>T. violacea </i>Harv.<i> </i>plants were inoculated by drenching with different concentrations of <i>B. bassiana</i> conidia. This dataset improves our understanding of the relationship between plants and endophytic fungi. This Faculty Research Ethics Committee of the Faculty of Applied Sciences granted ethics approval for this study, Reference no 212274759/1/2019.
DOI: 10.6084/m9.figshare.25224689
title: Supplementary Material for: Implementing Approach Bias Modification as Add-on to Varieties of Clinical Treatment for Alcohol Use Disorders: Results of a Multi-Center RCT

description: Introduction: Abstinence rates after inpatient treatment for alcohol use disorder (AUD) are modest (one-year rate around 50%). One promising approach is to re-train the automatically activated action tendency to approach alcohol-related stimuli (alcohol-approach bias) in AUD patients, as add-on to regular treatment. As efficacy has been demonstrated in well-controlled randomized controlled trials, the important next step is to add alcohol-approach-bias modification (alcohol-ApBM) to varieties of existing treatments for AUD. Therefore, this prospective, multicenter implementation-RCT examined whether adding alcohol-ApBM to regular treatments (various abstinence-oriented treatments including both individual and group-based interventions) would significantly increase abstinence rates compared to receiving regular treatment only, in a variety of naturalistic settings with different therapeutic approaches.

Methods: A total of 1586 AUD inpatients from 9 German rehabilitation clinics were randomly assigned to receive either ApBM in addition to regular treatment or not. Training satisfaction of patients and therapists was measured after training. Success rates were determined at 3-, 6-, and 12-months post-treatment.

Results: Return rates of the post-treatment assessments varied greatly between clinics, often being low (18%-76%). Nevertheless, ApBM significantly increased success rates after 3 months. After 6 and 12 months, the differences were not significant. ApBM was evaluated mostly positively by patients and therapists.

Discussion/Conclusion: ApBM was an effective add-on to regular treatment of AUD at 3-months follow-up, across a variety of AUD treatment settings. However, low return rates for the clinical outcomes reduced the effect size of ApBM considerably. The application of ApBM proved feasible in varying clinical settings, offering the opportunity to modify automatic processes and to promote abstinence.
DOI: 10.6084/m9.figshare.8129357.v1
title: Additional file 1: of Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer

description: Support file containing the Age (G), cigarettes (0:negative, 1:positive), Alcohol (0:negative, 1:positive), chronic bronchitis (0:negative, 1:positive), diabetes (0:negative, 1:positive), tumor history (0:negative, 1:positive), tumor family history (0:negative, 1:positive), blood type (0:A,1:B,2:O,3:AB), Neutrophil(G), Lymphocyte(G), N/L(G), Platelet(G), Serum Albumin(G), ALP(G), Serum Globulin(G), Al/Gl ratio(G), APTT(G), PT(G), CEA(G), CYFRA211(G), NSE(G), Tumor size(G), Tumor location (0:right upper,1:right middle,2:right lower,3:left upper,4:left lower,5:Ipsilateral), Tumor location(G), Pathology (0:AdCa,1:SqCa,2:Adenocarcinoma in situ,3:other), Pathology(G),Grade (G), Pathological morphology (1:lepidic, 2:Acinar, 3:Micropapillary, 4:Papillary, 5:solid), Pathological morphology(G), Pulmonary membrane invasion (0:negative, 1:positive), Bronchial mucosa and cartilage invasion (0:negative, 1:positive), Vascular invasion (0:negative, 1:positive), Nerve invasion (0:negative, 1:positive), Lobe-specific mediastinal lymph nodes (1:metastasis 0:no metastasis),Lobe non-specific mediastinal lymph nodes (1:metastasis 0:no metastasis), skiping mediastinal lymph nodes (1:metastasis 0:no metastasis),2, 4station(1:metastasis 0:no metastasis),5, 6station(1:metastasis 0:no metastasis),7station(1:metastasis 0:no metastasis),8station(1:metastasis 0:no metastasis), 9station(1:metastasis 0:no metastasis), hilar lymph nodes (10 station)(1:metastasis 0:no metastasis), interlobe lymph nodes (11 station)(1,metastasis 0,no metastasis) described in categorical variables and Age ranges (yrs), number of cigarettes, Tumor size (cm). Neutrophil, Lymphocyte, N/L, Platelet, Serum Albumin, ALP, Serum Globulin, Al/Gl ratio, APTT, PT, CEA, CYFRA211, NSE described in continuous variables. (XLSX 173 kb)
DOI: 10.6084/m9.figshare.7138715.v1
title: Additional file 4: of Identification, characterization and expression analysis of the VQ motif-containing gene family in tea plant (Camellia sinensis)

description: Table S3. List of predicted known microRNA target sites of CsVQ transcripts. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8129381.v1
title: Additional file 10: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S6. Univariate and multivariate Cox regression analyses in high-risk group of non-G-CIMP (or HSPB2 hypomethylated IDH1R132H wt) GBMs. (XLSX 23 kb)
DOI: 10.6084/m9.figshare.8129414
title: Additional file 2: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S1. Sample information of discovery and validation cohorts. (XLSX 16 kb)
DOI: 10.25381/cput.24565216.v1
title: Data Set for : <b>ANALYSIS OF FACTORS AFFECTING THE IMPLEMENTATION OF HEALTH AND SAFETY MANAGEMENT SYSTEMS IN CONSTRUCTION INDUSTRIES IN THE WESTERN CAPE, SOUTH AFRICA</b>

description: Ethical Reference #: 2021FEBEREC-STD-141
<br>
This study aimed to analyse the factors affecting the implementation of an OHSMS in the construction industry of the Western Cape, South Africa, by focusing on challenges associated with the implementation thereof. The research objectives were to identify factors that affect the implementation of an OHSMS on construction sites, to analyse the effect of integrating the Plan Do Check Act (PDCA) method on the implementation of OHSMS, to assess the effect of COVID-19 regulations on OHSMS implementation, and to evaluate how risk management is integrated into OHS during the implementation of an OHSMS.
The research questionnaire was structured to obtain opinions about OHSMS implementation in the Western Cape from construction professionals, including safety practitioners. A stratified random sampling method was used. The questionnaires were distributed online, and the reliability of the results was tested using the Cronbach’s alpha coefficient reliability test. The quantitative data were analysed using the Statistical Package for Social Sciences (SPSS) software version 27.0, and data were interpreted through frequencies, descriptive statistics, and multi-regression analysis. A multi-regression test was conducted to determine the relationship between internal and external factors and the implementation of OHSMS, including the use of the PDCA method, COVID-19, and the risk management plan.
The findings reveal that both internal and external factors affect OHSMS implementation. The most important internal factors identified are risk control strategies, senior management commitment and support, communication channels, and risk awareness. The most common external factors identified include pressure from clients on project delivery, company reputation, OHS enforcement, and government legislation. Furthermore, the study found that PDCA is the most common method used when implementing an OHSMS, and a risk management plan should be integrated into the OHSMS during the planning stage. Lastly, COVID-19 affected the implementation of the OHSMS and construction organisations operations.
A framework was developed to outline how an OHSMS can be implemented based on the findings from this study. The framework can be adopted by the construction industry to ensure effectiveness when implementing their OHSMS. OHSMS implementation ensures a reduction in accidents on-site.
<br>
DOI: 10.6084/m9.figshare.14944930.v1
title: Additional file 6 of Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells

description: Additional file 6: Table S5. Summary of CNVs containing TEs in naïve and primed PSCs in two different genetic background cell lines.
DOI: 10.6084/m9.figshare.14944933.v1
title: Additional file 7 of Elevated retrotransposon activity and genomic instability in primed pluripotent stem cells

description: Additional file 7: Table S6. Key resource table.
DOI: 10.6084/m9.figshare.19663712
title: Additional file 5 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 5: Table S3. The global and regional age-standardized variation trends of hypertensive heart disease from 1990 to 2019.
DOI: 10.6084/m9.figshare.19663712.v1
title: Additional file 5 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 5: Table S3. The global and regional age-standardized variation trends of hypertensive heart disease from 1990 to 2019.
DOI: 10.6084/m9.figshare.19663709
title: Additional file 4 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 4: Table S2. The age-standardized rate of hypertensive heart disease in different SDI regions.
DOI: 10.6084/m9.figshare.19663715
title: Additional file 6 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 6: Table S4. The prevalence, death and DALYs of hypertensive heart disease in different regions.
DOI: 10.6084/m9.figshare.19663715.v1
title: Additional file 6 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 6: Table S4. The prevalence, death and DALYs of hypertensive heart disease in different regions.
DOI: 10.6084/m9.figshare.19663706
title: Additional file 3 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 3: Table S1. The global and regional burden of hypertensive heart disease.
DOI: 10.6084/m9.figshare.19663706.v1
title: Additional file 3 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 3: Table S1. The global and regional burden of hypertensive heart disease.
DOI: 10.6084/m9.figshare.19663718
title: Additional file 7 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 7: Table S5. The age-standardized rate of hypertensive heart disease in different regions.
DOI: 10.6084/m9.figshare.19663718.v1
title: Additional file 7 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 7: Table S5. The age-standardized rate of hypertensive heart disease in different regions.
DOI: 10.6084/m9.figshare.19663709.v1
title: Additional file 4 of Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019

description: Additional file 4: Table S2. The age-standardized rate of hypertensive heart disease in different SDI regions.
DOI: 10.6084/m9.figshare.14944957
title: Additional file 5 of Construction of lncRNA-related competing endogenous RNA network and identification of hub genes in recurrent implantation failure

description: Additional file 5: Table S3. Predicted lncRNA-miRNA and mRNA-miRNA pairs for the seven hub lncRNA-related ceRNA networks. ceRNA, competing endogenous RNA.
DOI: 10.6084/m9.figshare.8129528
title: Additional file 3: of Biological and RNA regulatory function of MOV10 in mammalian germ cells

description: Table S4. CLIP reads predominantly mapping to miRNA precursors. (XLSX 157 kb)
DOI: 10.6084/m9.figshare.8129417.v1
title: Additional file 3: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S2. The primer sequences for PCR and pyrosequencing. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.7138715
title: Additional file 4: of Identification, characterization and expression analysis of the VQ motif-containing gene family in tea plant (Camellia sinensis)

description: Table S3. List of predicted known microRNA target sites of CsVQ transcripts. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8129438.v1
title: Additional file 6: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S3. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with RT/TMZ. (XLSX 27 kb)
DOI: 10.6084/m9.figshare.14945699
title: Effect of levosimendan on renal function in background of left ventricular dysfunction: a meta-analysis of randomized trials

description: Levosimendan, an inotrope, is widely used in the management of heart failure (HF) and cardiac surgery, but it remains uncertain whether levosimendan can improve renal function in patients with left ventricular dysfunction (LVD). PubMed, Embase, and Cochrane CENTRAL from the inception to June 2020 were systematically screened for randomized controlled trials (RCTs) to investigate whether levosimendan offers kidney-related advantages in cardiovascular patients with LVD. We pooled the effects using a random-effect model. Twenty-eight studies enrolling 5069 patients were included. Levosimendan reduced the sCr (SMD −0.28, 95% CI (−0.48, −0.09), P = 0.005, I<sup>2</sup> = 52.5%, high quality) and the risk of ARF (relative risk 0.75, 95%CI (0.60, 0.95), P = 0.017, I<sup>2</sup> = 11.3%, moderate-quality) in patients with LVD compared with control group. The reduction of sCr was more pronounced in patients with a relatively higher baseline sCr level. For secondary outcomes, levosimendan therapy was associated with the improvement of GFR (SMD 0.32, 95%CI (−0.05, 0.68), P = 0.092, I<sup>2</sup> = 55.1%, low-quality) and urine output (SMD 0.42, 95%CI (0.06, 0.79), P = 0.024, I<sup>2</sup> = 50.0%, very low-quality), but there was no significant reduction in BUN (SMD −0.14, 95%CI (−0.97, 0.70), P = 0.774, I<sup>2</sup> = 77.9%, very low-quality). Levosimendan might improve renal function of patients with LVD.
DOI: 10.6084/m9.figshare.8129528.v1
title: Additional file 3: of Biological and RNA regulatory function of MOV10 in mammalian germ cells

description: Table S4. CLIP reads predominantly mapping to miRNA precursors. (XLSX 157 kb)
DOI: 10.6084/m9.figshare.8129540
title: Additional file 4: of Biological and RNA regulatory function of MOV10 in mammalian germ cells

description: Table S5. MOV10-bound miRNAs and their category of maturity. (XLSX 18 kb)
DOI: 10.6084/m9.figshare.8129438
title: Additional file 6: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S3. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with RT/TMZ. (XLSX 27 kb)
DOI: 10.6084/m9.figshare.8129540.v1
title: Additional file 4: of Biological and RNA regulatory function of MOV10 in mammalian germ cells

description: Table S5. MOV10-bound miRNAs and their category of maturity. (XLSX 18 kb)
DOI: 10.6084/m9.figshare.7138730.v1
title: Additional file 5: of Identification, characterization and expression analysis of the VQ motif-containing gene family in tea plant (Camellia sinensis)

description: Table S4. List of predicted novel microRNA target sites of CsVQ transcripts. (XLSX 17 kb)
DOI: 10.6084/m9.figshare.7138748
title: Additional file 6: of Identification, characterization and expression analysis of the VQ motif-containing gene family in tea plant (Camellia sinensis)

description: Table S5. List of predicted microRNAs targeting CsVQ genes. (XLSX 10 kb)
DOI: 10.6084/m9.figshare.8129462
title: Additional file 9: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S5. Univariate and multivariate Cox regression analyses in low-risk group of non-G-CIMP (or HSPB2 hypermethylated IDH1R132H wt) GBMs. (XLSX 23 kb)
DOI: 10.6084/m9.figshare.8129447
title: Additional file 7: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S4. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with RT alone. (XLSX 25 kb)
DOI: 10.6084/m9.figshare.8129447.v1
title: Additional file 7: of Novel predictive epigenetic signature for temozolomide in non-G-CIMP glioblastomas

description: Table S4. Univariate and multivariate Cox regression analyses in non-G-CIMP/IDH1R132H wt GBMs with RT alone. (XLSX 25 kb)
DOI: 10.6084/m9.figshare.14944954.v1
title: Additional file 4 of Construction of lncRNA-related competing endogenous RNA network and identification of hub genes in recurrent implantation failure

description: Additional file 4: Table S2. Predicted lncRNA-miRNA and mRNA-miRNA pairs for WGCNA modules. WGCNA, weighted gene co‐expression network analysis.